Researchers Overview is a topic within the NeuroWiki knowledge base covering aspects of neurodegenerative disease research and mechanisms.
This section features leading researchers in neurodegenerative disease research. Understanding who drives advances in the field helps identify key opinion leaders, potential collaborators, and emerging research areas.[1]
The Alzheimer's disease research community has made significant advances in understanding disease mechanisms and developing therapeutic approaches. Key research areas include:[2]
Parkinson's disease research focuses on alpha-synuclein biology, mitochondrial dysfunction, and LRRK2 kinase:[6]
The ALS/FTD research community has made rapid progress in understanding disease genetics and mechanisms:[7]
Neuroinflammation is increasingly recognized as a central mechanism across neurodegenerative diseases:[8]
Large-scale genetic studies have identified numerous risk loci:
Major research institutions drive neurodegenerative disease research through dedicated centers and programs:
The NeuroWiki database tracks researcher coverage across major institutions:
| Institution | Researchers |
|---|---|
| University College London | 15+ |
| Harvard Medical School | 12+ |
| Mayo Clinic | 10+ |
| Stanford University | 8+ |
| University of Pennsylvania | 8+ |
See all 158 researchers pages...
Nature Index. Neuroscience. 2024. ↩︎
Scheltens P, et al. Alzheimer's disease. The Lancet. 2021. ↩︎
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems. Science. 2002. ↩︎
Goedert M, et al. Tau protein in neurodegeneration. Journal of Molecular Biology. 2022. ↩︎
Deczkowska A, et al. TREM2, a microglial receptor, in Alzheimer disease. Nature Reviews Neurology. 2023. ↩︎
Kalia LV, Lang AE. Parkinson's disease. The Lancet. 2015. ↩︎
Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016. ↩︎
Heneka MT, et al. Neuroinflammation in Alzheimer's disease. The Lancet Neurology. 2015. ↩︎